{"transactions":[{"id":1091641,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Finance"}}],"security":"Restricted Stock Units","published_at":"2025-07-08T00:00:05.000Z","date":"2025-06-21","kind":"exercise","planned":false,"acquired":true,"shares":30,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit converts into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 21, 2021, the reporting person was granted 118 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 21, 2021, the reporting person was granted 118 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":30},"source":{"system":"sec-edgar","filing":"0001641172-25-018063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000164117225018063/ownership.xml","form_type":"4"}},{"id":1091640,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Finance"}}],"security":"Common Stock","published_at":"2025-07-08T00:00:05.000Z","date":"2025-06-21","kind":"exercise","planned":false,"acquired":true,"shares":30,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converts into one share of common stock."}],"balance_after":110,"source":{"system":"sec-edgar","filing":"0001641172-25-018063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000164117225018063/ownership.xml","form_type":"4"}},{"id":1278032,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Finance"}}],"security":"Stock Option (Right to buy)","published_at":"2025-02-11T00:00:11.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter."}],"balance_after":150000,"derivative":{"exercise_price":0.34,"expiration_date":"2035-02-07","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-25-005721","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315225005721/ownership.xml","form_type":"4"}},{"id":1470127,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Finance"}}],"security":"Restricted Stock Units","published_at":"2024-06-25T20:32:47.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":false,"shares":437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit converts into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 21, 2021, the reporting person was granted 1,750 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 21, 2021, the reporting person was granted 1,750 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date."}],"balance_after":437,"derivative":{"underlying":"Common Stock","underlying_shares":437},"source":{"system":"sec-edgar","filing":"0001493152-24-025105","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315224025105/ownership.xml","form_type":"4"}},{"id":1470126,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Finance"}}],"security":"Common Stock","published_at":"2024-06-25T20:32:47.000Z","date":"2024-06-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":180,"price":1.94,"value":349.2,"ownership":{"direct":true},"balance_after":1185,"source":{"system":"sec-edgar","filing":"0001493152-24-025105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315224025105/ownership.xml","form_type":"4"}},{"id":1470125,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Finance"}}],"security":"Common Stock","published_at":"2024-06-25T20:32:47.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":true,"shares":437,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converts into one share of common stock."}],"balance_after":1365,"source":{"system":"sec-edgar","filing":"0001493152-24-025105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315224025105/ownership.xml","form_type":"4"}},{"id":1534305,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"officer":true,"officer_title":"Sr. VP of Finance"}}],"security":"Stock Option (Right to buy)","published_at":"2024-04-29T20:30:59.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in an initial installment of one-third on the one-year anniversary of the grant date, and the remaining shares shall vest in 24 substantially equal monthly installments thereafter."}],"balance_after":80000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-04-26","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001140361-24-023012","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036124023012/form4.xml","form_type":"4"}},{"id":1845993,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"officer":true,"officer_title":"Vice President of Finance"}}],"security":"Restricted Stock Units","published_at":"2023-06-24T00:30:16.000Z","date":"2023-06-21","kind":"exercise","planned":false,"acquired":false,"shares":438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit converts into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 21, 2021, the reporting person was granted 1,750 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 21, 2021, the reporting person was granted 1,750 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":874,"derivative":{"underlying":"Common Stock","underlying_shares":438},"source":{"system":"sec-edgar","filing":"0001140361-23-031258","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036123031258/form4.xml","form_type":"4"}},{"id":1845992,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"officer":true,"officer_title":"Vice President of Finance"}}],"security":"Common Stock","published_at":"2023-06-24T00:30:16.000Z","date":"2023-06-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":179,"price":2.48,"value":443.92,"ownership":{"direct":true},"balance_after":928,"source":{"system":"sec-edgar","filing":"0001140361-23-031258","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036123031258/form4.xml","form_type":"4"}},{"id":1845991,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"officer":true,"officer_title":"Vice President of Finance"}}],"security":"Common Stock","published_at":"2023-06-24T00:30:16.000Z","date":"2023-06-21","kind":"exercise","planned":false,"acquired":true,"shares":438,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converts into one share of common stock."}],"balance_after":1107,"source":{"system":"sec-edgar","filing":"0001140361-23-031258","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036123031258/form4.xml","form_type":"4"}},{"id":2223595,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"officer":true,"officer_title":"Vice President of Finance"}}],"security":"Restricted Stock Units","published_at":"2022-06-24T00:31:02.000Z","date":"2022-06-21","kind":"exercise","acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit converts into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 21, 2021, the reporting person was granted 35,000 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 21, 2021, the reporting person was granted 35,000 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":26250,"derivative":{"underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001140361-22-023928","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122023928/form4.xml","form_type":"4"}},{"id":2223594,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"officer":true,"officer_title":"Vice President of Finance"}}],"security":"Common Stock","published_at":"2022-06-24T00:31:02.000Z","date":"2022-06-21","kind":"tax_withholding","acquired":false,"shares":3586,"price":0.4765,"value":1708.729,"ownership":{"direct":true},"balance_after":13367,"source":{"system":"sec-edgar","filing":"0001140361-22-023928","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122023928/form4.xml","form_type":"4"}},{"id":2223593,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"officer":true,"officer_title":"Vice President of Finance"}}],"security":"Common Stock","published_at":"2022-06-24T00:31:02.000Z","date":"2022-06-21","kind":"exercise","acquired":true,"shares":8750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converts into one share of common stock."}],"balance_after":16953,"source":{"system":"sec-edgar","filing":"0001140361-22-023928","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122023928/form4.xml","form_type":"4"}},{"id":2329639,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"officer":true,"officer_title":"Vice President of Finance"}}],"security":"Stock Option (Right to buy)","published_at":"2022-03-18T01:00:32.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":114500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable in 36 substantially equal monthly installments from the grant date."}],"balance_after":114500,"derivative":{"exercise_price":1.93,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":114500},"source":{"system":"sec-edgar","filing":"0001140361-22-009983","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122009983/form4.xml","form_type":"4/A","original_submission_date":"2022-03-15"}},{"id":2334482,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"officer":true,"officer_title":"Vice President of Finance"}}],"security":"Stock Option (Right to buy)","published_at":"2022-03-16T01:34:30.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":114500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over three years, with 25% of the options vesting on the one-year anniversary of the grant date and the remaining options vesting in 24 substantially equal monthly installments thereafter."}],"balance_after":114500,"derivative":{"exercise_price":1.93,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":114500},"source":{"system":"sec-edgar","filing":"0001140361-22-009663","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122009663/form4.xml","form_type":"4"}},{"id":2659765,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"officer":true,"officer_title":"Vice President of Finance"}}],"security":"Restricted Stock Unit","published_at":"2021-06-22T22:01:13.000Z","date":"2021-06-21","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in four equal installments on June 21 of each of 2022, 2023, 2024 and 2025, provided they shall vest in full immediately prior to a Change in Control (as defined in Ms. Gurrola's Executive Employment Agreement, dated as of June 16, 2021 and effective as of June 21, 2021), subject to continued service through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option vests and becomes exercisable in four equal installments on June 21 of each of 2022, 2023, 2024 and 2025, provided they shall vest in full immediately prior to a Change in Control (as defined in Ms. Gurrola's Executive Employment Agreement, dated as of June 16, 2021 and effective as of June 21, 2021), subject to continued service through each vesting date."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001140361-21-021928","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036121021928/form4.xml","form_type":"4"}},{"id":2771410,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"officer":true,"officer_title":"Former SVP of Finance"}}],"security":"Common Stock","published_at":"2021-03-27T01:53:07.000Z","date":"2021-03-24","kind":"tax_withholding","acquired":false,"shares":6094,"price":2.67,"value":16270.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred in connection with the closing of the merger (the \"Merger\") contemplated by the Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") by and among NTN Buzztime Inc., BIT Merger Sub, Inc. and Brooklyn Immunotherapeutics LLC.  The number of shares withheld was determinable on March 24, 2021. No shares were sold in connection with this transaction. None of the share amounts in this Form 4 reflect the 2 for 1 reverse stock split implemented by the issuer on March 25, 2021 in connection with the Merger."}],"balance_after":21617,"source":{"system":"sec-edgar","filing":"0001140361-21-010363","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036121010363/form4.xml","form_type":"4"}},{"id":2776993,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2021-03-22T23:00:15.000Z","date":"2021-03-19","kind":"tax_withholding","acquired":false,"shares":116,"price":3.53,"value":409.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on March 19, 2021. No shares were sold in connection with this transaction."}],"balance_after":27711,"source":{"system":"sec-edgar","filing":"0001493152-21-006563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315221006563/ownership.xml","form_type":"4"}},{"id":2844965,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2021-02-22T22:30:17.000Z","date":"2021-02-19","kind":"tax_withholding","acquired":false,"shares":115,"price":4.81,"value":553.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on February 19, 2021. No shares were sold in connection with this transaction."}],"balance_after":27827,"source":{"system":"sec-edgar","filing":"0001493152-21-004520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315221004520/ownership.xml","form_type":"4"}},{"id":2903651,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2021-01-20T22:30:10.000Z","date":"2021-01-19","kind":"tax_withholding","acquired":false,"shares":1400,"price":2.55,"value":3570.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on January 19, 2021. No shares were sold in connection with this transaction."}],"balance_after":27942,"source":{"system":"sec-edgar","filing":"0001493152-21-001453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315221001453/ownership.xml","form_type":"4"}},{"id":2936952,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2020-12-22T01:00:08.000Z","date":"2020-12-19","kind":"tax_withholding","acquired":false,"shares":100,"price":2.17,"value":217.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on December 19, 2020. No shares were sold in connection with this transaction."}],"balance_after":29342,"source":{"system":"sec-edgar","filing":"0001493152-20-024074","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220024074/ownership.xml","form_type":"4"}},{"id":2972417,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2020-11-20T23:00:09.000Z","date":"2020-11-20","kind":"tax_withholding","acquired":false,"shares":98,"price":1.88,"value":184.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on November 20, 2020. No shares were sold in connection with this transaction."}],"balance_after":29442,"source":{"system":"sec-edgar","filing":"0001493152-20-022147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220022147/ownership.xml","form_type":"4"}},{"id":3002545,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2020-10-22T00:00:11.000Z","date":"2020-10-21","kind":"tax_withholding","acquired":false,"shares":1178,"price":2.05,"value":2414.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on October 21, 2020. No shares were sold in connection with this transaction."}],"balance_after":29540,"source":{"system":"sec-edgar","filing":"0001493152-20-019770","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220019770/ownership.xml","form_type":"4"}},{"id":3024258,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2020-09-23T23:15:41.000Z","date":"2020-09-22","kind":"tax_withholding","acquired":false,"shares":97,"price":1.99,"value":193.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on September 22, 2020. No shares were sold in connection with this transaction."}],"balance_after":30718,"source":{"system":"sec-edgar","filing":"0001493152-20-018250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220018250/ownership.xml","form_type":"4"}},{"id":3047196,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2020-08-26T23:05:12.000Z","date":"2020-08-25","kind":"tax_withholding","acquired":false,"shares":98,"price":2.62,"value":256.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on August 25, 2020. No shares were sold in connection with this transaction."}],"balance_after":30815,"source":{"system":"sec-edgar","filing":"0001493152-20-016789","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220016789/ownership.xml","form_type":"4"}},{"id":3075372,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2020-07-28T22:00:16.000Z","date":"2020-07-28","kind":"tax_withholding","acquired":false,"shares":1178,"price":1.85,"value":2179.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on July 28, 2020. No shares were sold in connection with this transaction."}],"balance_after":30913,"source":{"system":"sec-edgar","filing":"0001493152-20-014118","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220014118/ownership.xml","form_type":"4"}},{"id":3097230,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2020-06-30T20:30:35.000Z","date":"2020-06-29","kind":"tax_withholding","acquired":false,"shares":97,"price":3.15,"value":305.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on June 29, 2020. No shares were sold in connection with this transaction."}],"balance_after":32091,"source":{"system":"sec-edgar","filing":"0001493152-20-012284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220012284/ownership.xml","form_type":"4"}},{"id":3141844,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2020-05-20T23:12:52.000Z","date":"2020-05-20","kind":"tax_withholding","acquired":false,"shares":115,"price":1.55,"value":178.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on May 20, 2020. No shares were sold in connection with this transaction."}],"balance_after":32188,"source":{"system":"sec-edgar","filing":"0001493152-20-009579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220009579/ownership.xml","form_type":"4"}},{"id":3172108,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2020-04-22T12:01:19.000Z","date":"2020-04-21","kind":"tax_withholding","acquired":false,"shares":1392,"price":1.21,"value":1684.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on April 21, 2020. No shares were sold in connection with this transaction."}],"balance_after":32303,"source":{"system":"sec-edgar","filing":"0001493152-20-006884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220006884/ownership.xml","form_type":"4"}},{"id":3195713,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2020-03-26T01:07:54.000Z","date":"2020-03-25","kind":"tax_withholding","acquired":false,"shares":114,"price":1.48,"value":168.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on March 25, 2020. No shares were sold in connection with this transaction."}],"balance_after":33695,"source":{"system":"sec-edgar","filing":"0001493152-20-004751","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220004751/ownership.xml","form_type":"4"}},{"id":3247798,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2020-02-26T13:00:44.000Z","date":"2020-02-25","kind":"tax_withholding","acquired":false,"shares":115,"price":2.05,"value":235.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was\ndeterminable on February 25, 2020. No shares were sold in connection with this transaction."}],"balance_after":33809,"source":{"system":"sec-edgar","filing":"0001493152-20-002967","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220002967/ownership.xml","form_type":"4"}},{"id":3297387,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2020-02-01T01:00:11.000Z","date":"2020-01-29","kind":"tax_withholding","acquired":false,"shares":114,"price":2.43,"value":277.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on January 29, 2020. No shares were sold in connection with this transaction."}],"balance_after":33924,"source":{"system":"sec-edgar","filing":"0001493152-20-001470","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220001470/ownership.xml","form_type":"4"}},{"id":3297386,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2020-02-01T01:00:11.000Z","date":"2020-01-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares subject to a restricted stock unit award granted under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The award will vest as to 12.5% of the shares subject to the award on the three-month anniversary of the grant date and on each three month anniversary thereafter in substantially equal installments, in each case, subject to the reporting person's continued service to the issuer as of the applicable vesting date."}],"balance_after":34038,"source":{"system":"sec-edgar","filing":"0001493152-20-001470","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220001470/ownership.xml","form_type":"4"}},{"id":3334775,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2019-12-20T22:00:20.000Z","date":"2019-12-19","kind":"tax_withholding","acquired":false,"shares":94,"price":2.73,"value":256.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on December 19, 2019. No shares were sold in connection with this transaction."}],"balance_after":9038,"source":{"system":"sec-edgar","filing":"0001493152-19-019539","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219019539/ownership.xml","form_type":"4"}},{"id":3365158,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2019-11-21T01:00:11.000Z","date":"2019-11-20","kind":"tax_withholding","acquired":false,"shares":95,"price":2.62,"value":248.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on November 20, 2019. No shares were sold in connection with this transaction."}],"balance_after":9132,"source":{"system":"sec-edgar","filing":"0001493152-19-018146","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219018146/ownership.xml","form_type":"4"}},{"id":3389617,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2019-10-23T23:00:48.000Z","date":"2019-10-23","kind":"tax_withholding","acquired":false,"shares":94,"price":2.88,"value":270.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on October 23, 2019. No shares were sold in connection with this transaction."}],"balance_after":9277,"source":{"system":"sec-edgar","filing":"0001493152-19-015892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219015892/ownership.xml","form_type":"4"}},{"id":3407500,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2019-09-24T23:40:38.000Z","date":"2019-09-24","kind":"tax_withholding","acquired":false,"shares":454,"price":2.28,"value":1035.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on September 24, 2019. No shares were sold in connection with this transaction."}],"balance_after":9321,"source":{"system":"sec-edgar","filing":"0001493152-19-014523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219014523/ownership.xml","form_type":"4"}},{"id":3428810,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2019-08-27T21:35:01.000Z","date":"2019-08-27","kind":"tax_withholding","acquired":false,"shares":35,"price":2.77,"value":96.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on August 27, 2019. No shares were sold in connection with this transaction."}],"balance_after":9775,"source":{"system":"sec-edgar","filing":"0001493152-19-013435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219013435/ownership.xml","form_type":"4"}},{"id":3454084,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2019-07-31T00:00:22.000Z","date":"2019-07-30","kind":"tax_withholding","acquired":false,"shares":34,"price":3.18,"value":108.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on July 30, 2019. No shares were sold in connection with this transaction."}],"balance_after":9810,"source":{"system":"sec-edgar","filing":"0001493152-19-011370","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219011370/ownership.xml","form_type":"4"}},{"id":3480735,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2019-06-24T21:00:12.000Z","date":"2019-06-21","kind":"tax_withholding","acquired":false,"shares":34,"price":3.47,"value":117.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on June 21, 2019. No shares were sold in connection with this transaction."}],"balance_after":9844,"source":{"system":"sec-edgar","filing":"0001493152-19-009631","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219009631/ownership.xml","form_type":"4"}},{"id":3517717,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2019-05-21T23:36:51.000Z","date":"2019-05-21","kind":"tax_withholding","acquired":false,"shares":35,"price":2.89,"value":101.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on May 21, 2019. No shares were sold in connection with this transaction."}],"balance_after":9878,"source":{"system":"sec-edgar","filing":"0001493152-19-008041","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219008041/ownership.xml","form_type":"4"}},{"id":3549578,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2019-04-25T20:45:40.000Z","date":"2019-04-23","kind":"tax_withholding","acquired":false,"shares":34,"price":3.8,"value":129.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on April 23, 2019. No shares were sold in connection with this transaction."}],"balance_after":9913,"source":{"system":"sec-edgar","filing":"0001493152-19-005945","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219005945/ownership.xml","form_type":"4"}},{"id":3577980,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2019-03-27T23:30:33.000Z","date":"2019-03-26","kind":"tax_withholding","acquired":false,"shares":34,"price":3.72,"value":126.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on March 26, 2019. No shares were sold in connection with this transaction."}],"balance_after":9947,"source":{"system":"sec-edgar","filing":"0001493152-19-004045","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219004045/ownership.xml","form_type":"4"}},{"id":3584115,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2019-03-21T20:45:21.000Z","date":"2019-03-19","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares subject to a restricted stock unit award granted under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan. The award will vest as to 16.67% of the shares subject to the award on the 6-month anniversary of the grant date and the remaining 83.33% of the shares will vest in 30 substantially equal monthly installments beginning on the 7-month anniversary of the grant date, in each case, subject to the reporting person's continued service to the issuer as of the applicable vesting date."}],"balance_after":9981,"source":{"system":"sec-edgar","filing":"0001493152-19-003713","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219003713/ownership.xml","form_type":"4"}},{"id":3634458,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2019-02-26T22:00:26.000Z","date":"2019-02-26","kind":"tax_withholding","acquired":false,"shares":35,"price":3.42,"value":119.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on February 26, 2019. No shares were sold in connection with this transaction."}],"balance_after":2981,"source":{"system":"sec-edgar","filing":"0001493152-19-002608","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219002608/ownership.xml","form_type":"4"}},{"id":3684586,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2019-01-30T01:00:13.000Z","date":"2019-01-29","kind":"tax_withholding","acquired":false,"shares":34,"price":3.18,"value":108.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on January 29, 2019. No shares were sold in connection with this transaction."}],"balance_after":3016,"source":{"system":"sec-edgar","filing":"0001493152-19-001142","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219001142/ownership.xml","form_type":"4"}},{"id":3724128,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2018-12-20T22:00:26.000Z","date":"2018-12-19","kind":"tax_withholding","acquired":false,"shares":28,"price":2,"value":56.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on December 19, 2018. No shares were sold in connection with this transaction."}],"balance_after":3050,"source":{"system":"sec-edgar","filing":"0001493152-18-017755","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315218017755/ownership.xml","form_type":"4"}},{"id":3758192,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-21T01:00:19.000Z","date":"2018-11-20","kind":"tax_withholding","acquired":false,"shares":29,"price":2.87,"value":83.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on November 20, 2018. No shares were sold in connection with this transaction."}],"balance_after":3078,"source":{"system":"sec-edgar","filing":"0001493152-18-016582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315218016582/ownership.xml","form_type":"4"}},{"id":3784558,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2018-10-24T12:30:34.000Z","date":"2018-10-23","kind":"tax_withholding","acquired":false,"shares":28,"price":4.32,"value":120.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on October 23, 2018. No shares were sold in connection with this transaction."}],"balance_after":3107,"source":{"system":"sec-edgar","filing":"0001493152-18-014818","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315218014818/ownership.xml","form_type":"4"}},{"id":3808719,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2018-09-25T20:30:17.000Z","date":"2018-09-25","kind":"tax_withholding","acquired":false,"shares":169,"price":4.23,"value":714.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on September 25, 2018. No shares were sold in connection with this transaction."}],"balance_after":3135,"source":{"system":"sec-edgar","filing":"0001493152-18-013715","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315218013715/ownership.xml","form_type":"4"}},{"id":3987063,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77675,"kind":"person","name":"Gurrola Sandra M","position":1,"cik":"0001618457","reported_name":"Gurrola Sandra M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2018-03-21T20:55:58.000Z","date":"2018-03-19","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares subject to a restricted stock unit award granted under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan.  The award will vest as to 16.67% of the shares subject to the award on the 6-month anniversary of the grant date and the remaining 83.33% of the shares will vest in 30 substantially equal monthly installments beginning on the 7-month anniversary of the grant date, in each case, subject to the reporting person's continued service to the issuer as of the applicable vesting date."}],"balance_after":3304,"source":{"system":"sec-edgar","filing":"0001493152-18-003716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315218003716/form4.xml","form_type":"4"}}]}